会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide
    • 2- {4 - [(3S) - 哌啶-3-基]苯基} -2H-吲唑-7-甲酰胺的药学上可接受的盐
    • US08436185B2
    • 2013-05-07
    • US12811922
    • 2009-01-08
    • Jennifer R. FoleyRobert Darrin Wilson
    • Jennifer R. FoleyRobert Darrin Wilson
    • C07D211/32A61K31/445
    • C07D401/10
    • The present invention relates to pharmaceutically acceptable salts of an amide substituted indazole which are inhibitors of the enzyme poly(ADP-ribose)polymerase (PARP), previously known as poly(ADP-ribose)synthase and poly(ADP-ribosyl) transferase. The compounds of the present invention are useful as mono-therapies in tumors with specific defects in DNA-repair pathways and as enhancers of certain DNA-damaging agents such as anticancer agents and radiotherapy. Further, the compounds of the present invention are useful for reducing cell necrosis (in stroke and myocardial infarction), down regulating inflammation and tissue injury, treating retroviral infections and protecting against the toxicity of chemotherapy.
    • 本发明涉及酰胺取代的吲唑的药学上可接受的盐,其是聚(ADP-核糖)聚合酶(PARP)的酶的抑制剂,先前称为聚(ADP-核糖)合成酶和聚(ADP-核糖基)转移酶。 本发明的化合物可用作在DNA修复途径中具有特定缺陷的肿瘤中的单一疗法,并且可用作某些DNA损伤剂如抗癌剂和放射疗法的增强剂。 此外,本发明的化合物可用于减少细胞坏死(中风和心肌梗塞),下调调节炎症和组织损伤,治疗逆转录病毒感染并防止化疗的毒性。